Literature DB >> 17958636

The natural history of chronic hepatitis B.

C-L Lai1, M-F Yuen.   

Abstract

The natural history of chronic hepatitis B is dependent on the age of acquiring the hepatitis B infection. Those who are infected at adolescence or adulthood (including most of the Caucasians) tend to have stable disease after hepatitis B e antigen seroconversion with normal serum alanine aminotransaminase (ALT) and hepatitis B virus (HBV) DNA levels <10(5) copies/mL (20 000 IU/mL). In contrast, those who are infected at birth or early childhood (including the majority of the world's hepatitis B carriers, i.e. Asians) have a prolonged immune tolerance phase followed by a prolonged immune clearance phase. A proportion of these patients have progressive disease after HBeAg seroconversion with HBV DNA <10(4) copies/mL (<2000 IU/mL) and ALT between 0.5 and 2x upper limit of normal. Core promoter mutations may play a part in the development of cirrhosis-related complications. However, continuing viral replication, even at a relatively low level of <10(4) copies/mL (<2000 IU/mL), is probably the most important factor for the development of complications.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17958636     DOI: 10.1111/j.1365-2893.2007.00909.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  17 in total

1.  Clinicopathological features and outcomes of young patients with hepatocellular carcinoma after hepatectomy.

Authors:  Kazuki Takeishi; Ken Shirabe; Jun Muto; Takeo Toshima; Akinobu Taketomi; Yoshihiko Maehara
Journal:  World J Surg       Date:  2011-05       Impact factor: 3.352

Review 2.  Potential mechanisms of hepatitis B virus induced liver injury.

Authors:  Mohd Suhail; Hany Abdel-Hafiz; Ashraf Ali; Kaneez Fatima; Ghazi A Damanhouri; Esam Azhar; Adeel Ga Chaudhary; Ishtiaq Qadri
Journal:  World J Gastroenterol       Date:  2014-09-21       Impact factor: 5.742

3.  Gender difference of alanine aminotransferase elevation may be associated with higher hemoglobin levels among male adolescents.

Authors:  Solomon Chih-Cheng Chen; Jun-Jun Yeh; Mei-Hwei Chang; Yu-Kuei Liao; Li-Chen Hsiao; Choo-Aun Neoh; Teck-Siang Tok; Jung-Der Wang
Journal:  PLoS One       Date:  2010-10-12       Impact factor: 3.240

4.  Peripheral T-lymphocyte subpopulations in different clinical stages of chronic HBV infection correlate with HBV load.

Authors:  Jing You; Lin Zhuang; Yi-Feng Zhang; Hong-Ying Chen; Hutcha Sriplung; Alan Geater; Virasakdi Chongsuvivatwong; Teerha Piratvisuth; Edward McNeil; Lan Yu; Bao-Zhang Tang; Jun-Hua Huang
Journal:  World J Gastroenterol       Date:  2009-07-21       Impact factor: 5.742

5.  Serum cytokine profile in patients with hepatitis B e antigen-negative chronic active hepatitis B and inactive hepatitis B virus carriers.

Authors:  Dimitra Dimitropoulou; Marina Karakantza; Georgios L Theodorou; Lydia Leonidou; Stelios F Assimakopoulos; Athanasia Mouzaki; Charalambos A Gogos
Journal:  World J Gastrointest Pathophysiol       Date:  2013-02-15

6.  Sex hormone influence on hepatitis in young male A/JCr mice infected with Helicobacter hepaticus.

Authors:  Elizabeth J Theve; Yan Feng; Koli Taghizadeh; Kathleen S Cormier; David R Bell; James G Fox; Arlin B Rogers
Journal:  Infect Immun       Date:  2008-06-16       Impact factor: 3.441

7.  Comparison of long-term immunogenicity (23 years) of 10 μg and 20 μg doses of hepatitis B vaccine in healthy children.

Authors:  Qian Wu; Gui-hua Zhuang; Xue-liang Wang; Tie-jun Hou; Dimpy P Shah; Xiao-li Wei; Li-rong Wang; Min Zhang
Journal:  Hum Vaccin Immunother       Date:  2012-08-01       Impact factor: 3.452

8.  Laparoscopic splenectomy in portal hypertension: a single-surgeon 13-year experience.

Authors:  Yuedong Wang; Xiaoli Zhan; Yangwen Zhu; Zhijie Xie; Jinhui Zhu; Zaiyuan Ye
Journal:  Surg Endosc       Date:  2009-12-22       Impact factor: 4.584

9.  High frequency of CD4+ CXCR5+ TFH cells in patients with immune-active chronic hepatitis B.

Authors:  Junyan Feng; Lu Lu; Cong Hua; Ling Qin; Pingwei Zhao; Juan Wang; Ye Wang; Wanyu Li; Xiaodong Shi; Yanfang Jiang
Journal:  PLoS One       Date:  2011-07-07       Impact factor: 3.240

Review 10.  Hepatitis B precore protein: pathogenic potential and therapeutic promise.

Authors:  Renae Walsh; Stephen Locarnini
Journal:  Yonsei Med J       Date:  2012-09       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.